Viewing Study NCT01882803


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-02-20 @ 6:20 PM
Study NCT ID: NCT01882803
Status: COMPLETED
Last Update Posted: 2023-09-07
First Post: 2013-05-31
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma
Sponsor: SecuraBio
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Indolent Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PI3K Inhibitor View